Comp. | Biological Interpretation | Compounds in Group A | Compounds in Group B | VolSurf Interpretation |
---|---|---|---|---|
1 | Classic growth factor signaling: (MAP and protein kinase signaling) | Sulfonamides, antibiotics, carbonic anhydrase inhibitors | Antipsychotic and antihistaminic compounds | High lipophilicity |
2 | DNA damage | Contrast agents, antibiotics, | DNA damaging agents, antimetabolites | Strong lipophilic areas emphasized |
3 | Stress response, mitochondrial and anabolic metabolism | DNA damaging agents | GPCR antagonists, ion channel blockers | Polar interactions enriched |
4 | Cytoskeleton, cell adhesion and migration | GPCR liganda, macrocyclic cmpds and contrast agents | Beta adrenergic agonists, other GPCR ligands | N/A |
5 | Differentiation, EMT, stemness | NSAIDS, cAMP signaling promoting compounds | HDAC Inhibitors, HDAC-like | Significantly enriched with pharmacophoric features* |
6 | Inflammatory and differentiation signaling | N/A | Protein synthesis inhibitors, anti-diabetics, cardiac glycosides | Pharmacophoric features* |
7 | GPCR and cytokine signaling | N/A | Cardiac glycosides, cephalosporins | Pharmacophoric features* |
8 | Growth factor and cell adhesion signaling | Cardiac glycosides | β-adrenergic agonists, Ca2+ channel blockers | Integy-moment and significant pharmacophoric enriched* |
9 | Amino acid and nitrogen metabolism | Protein synthesis inhibitors | Anti-diabetics | Integy-moment and significant pharmacophoric enriched* |
10 | Cancer signaling | DNA damaging agents | Corticosteroids, ionophores | Size shape type descriptors |